Cargando…
Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
Resistance to antiestrogen therapy remains a significant problem in breast cancer. Low expression of inhibitor of growth 4 (ING4) in primary tumors has been correlated with increased rates of recurrence in estrogen receptor-positive (ER+) breast cancer patients, suggesting a role for ING4 in ER sign...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117803/ https://www.ncbi.nlm.nih.gov/pubmed/27895513 http://dx.doi.org/10.2147/BCTT.S119691 |